AMYRA is developing a unique enzyme combination for curative care of Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS), which represent major public health issues.
AMYRA’s products have the potential to establish the standard of care and majorly impact the lives of affected people.
- https://www.amyra.com
- +41 61 515 07 70
- office@amyra.com
- Dr. Werner Tschollar
